Seoul Bio Hub, a bio and medical startup support platform established by the Seoul Metropolitan Government and jointly operated by the Korea Institute of Science and Technology (KIST) and Korea University, announced on the 29th that it will be promoting the '2025 Seoul Bio Hub-Daewon Pharmaceutical Open Innovation Program' in cooperation with Daewon Pharmaceutical.
This program aims to strengthen the technological capabilities of pharmaceutical and biotech startups and provide opportunities for collaboration with large corporations, and this is its second year. In particular, it plans to discover promising startups that are linked to Daewon Pharmaceutical’s technological needs and explore technological advancement and commercialization possibilities together.
The selected companies will receive practical growth opportunities such as technology verification and market entry through joint support from Seoul Bio Hub and Daewon Pharmaceutical. Seoul Bio Hub plans to provide customized programs such as corporate diagnosis, domestic and international expert consulting, and overseas market verification in conjunction with professional accelerators.
Based on its practical experience in the industrial field, Daewon Pharmaceutical conducts marketability assessments of startups’ technologies, provides feedback, and provides advice on pharmaceutical implementation. In addition, excellent companies among the selected startups are given the opportunity to participate in the ‘The Ham Program’ operated by Daewon Pharmaceutical.
The recruitment target is domestic startups established within the past 8 years, and the recruitment fields are related to Daewon Pharmaceutical's new business, such as △peptides, △small molecules, △drug delivery technology, and △device-based drug delivery technology. The final selection will be made to two companies through document and presentation evaluation.
Applications for participation can be submitted online through the Seoul Biohub website until 3:00 PM on Thursday, July 10th.
Kim Hyun-woo, head of the Seoul Bio Hub Business Group, said, “This collaboration will be a good example of the public and private sectors working together to create an open innovation ecosystem in the pharmaceutical and biotech sectors.” He added, “Seoul Bio Hub plans to continue expanding its support in various ways to help promising startups secure global competitiveness.”
- See more related articles
You must be logged in to post a comment.